AVANOS MEDICAL INC (AVNS) Stock Price, Forecast & Analysis
NYSE:AVNS • US05350V1061
AVNS Key Statistics, Chart & Performance
The current stock price of AVNS is 15.2 USD. In the past month the price increased by 23.08%. In the past year, price decreased by -1.62%.
AVNS Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to AVNS. When comparing the yearly performance of all stocks, AVNS is one of the better performing stocks in the market, outperforming 72.28% of all stocks.
AVNS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AVNS. AVNS has an average financial health and profitability rating.
AVNS Financial Highlights
Over the last trailing twelve months AVNS reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS decreased by -7.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.92% | ||
| ROE | -60.27% | ||
| Debt/Equity | 0.12 |
AVNS Forecast & Estimates
For the next year, analysts expect an EPS growth of -27.14% and a revenue growth 1.39% for AVNS
AVNS Ownership
AVNS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 31.9 | 60.641B | ||
| COO | COOPER COS INC/THE | 18.28 | 16.059B | ||
| ALGN | ALIGN TECHNOLOGY INC | 17.03 | 13.433B | ||
| SOLV | SOLVENTUM CORP | 11.57 | 12.789B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 20.11 | 4.837B | ||
| LNTH | LANTHEUS HOLDINGS INC | 12.93 | 4.726B | ||
| ICUI | ICU MEDICAL INC | 18.49 | 3.661B | ||
| HAE | HAEMONETICS CORP/MASS | 11.05 | 2.723B | ||
| XRAY | DENTSPLY SIRONA INC | 8.02 | 2.482B | ||
| NEOG | NEOGEN CORP | 32.88 | 2.391B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVNS
Company Profile
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Company Info
AVANOS MEDICAL INC
5405 Windward Parkway, Suite 100 South
Alpharetta GEORGIA 30004 US
CEO: Joseph F. Woody
Employees: 2227
Phone: 18444282667
AVANOS MEDICAL INC / AVNS FAQ
Can you describe the business of AVANOS MEDICAL INC?
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
What is the current price of AVNS stock?
The current stock price of AVNS is 15.2 USD. The price increased by 1.95% in the last trading session.
What is the dividend status of AVANOS MEDICAL INC?
AVNS does not pay a dividend.
How is the ChartMill rating for AVANOS MEDICAL INC?
AVNS has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Which stock exchange lists AVNS stock?
AVNS stock is listed on the New York Stock Exchange exchange.
What is the Price/Earnings (PE) ratio of AVANOS MEDICAL INC (AVNS)?
The PE ratio for AVANOS MEDICAL INC (AVNS) is 14.21. This is based on the reported non-GAAP earnings per share of 1.07 and the current share price of 15.2 USD.
How many employees does AVANOS MEDICAL INC have?
AVANOS MEDICAL INC (AVNS) currently has 2227 employees.